Cart
sales@molnova.com
Calcium dobesilate
CAS No. 20123-80-2
Calcium dobesilate( —— )
Catalog No. M20557 CAS No. 20123-80-2
Calcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG induced inflammation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 37 | In Stock |
|
| 1G | 52 | In Stock |
|
Biological Information
-
Product NameCalcium dobesilate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG induced inflammation.
-
DescriptionCalcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG induced inflammation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCardiovascular Disease
-
IndicationDiabetic microvascular disease varicose veins syndrome
Chemical Information
-
CAS Number20123-80-2
-
Formula Weight418.41
-
Molecular FormulaC12H10CaO10S2?
-
Purity>98% (HPLC)
-
SolubilityDMSO:150 mg/mL (358.50 mM)
-
SMILES[Ca++].Oc1ccc(O)c(c1)S([O-])(=O)=O.Oc1ccc(O)c(c1)S([O-])(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhou Y Yuan J Qi C et al.Calcium dobesilate may alleviate diabetes?induced endothelial dysfunction and inflammation.Mol Med Rep[J]. 2017 Dec;16(6):8635-8642.
molnova catalog
related products
-
PAR-4 Agonist Peptid...
PAR-4 Agonist Peptide, amide TFA (PAR-4-AP TFA; AY-NH2 TFA) is a proteinase-activated receptor-4 (PAR-4) agonist, which has no effect on either PAR-1 or PAR-2 and whose effects are blocked by a PAR-4 antagonist.
-
Astragenol
Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.
-
N-Biotinyl-6-aminohe...
N-Biotinyl-6-aminohexanoic acid can be used to perform N-terminal biotinylation.
